Karaglani, M.; Panagopoulou, M.; Cheimonidi, C.; Tsamardinos, I.; Maltezos, E.; Papanas, N.; Papazoglou, D.; Mastorakos, G.; Chatzaki, E.
Liquid Biopsy in Type 2 Diabetes Mellitus Management: Building Specific Biosignatures via Machine Learning. J. Clin. Med. 2022, 11, 1045.
https://doi.org/10.3390/jcm11041045
AMA Style
Karaglani M, Panagopoulou M, Cheimonidi C, Tsamardinos I, Maltezos E, Papanas N, Papazoglou D, Mastorakos G, Chatzaki E.
Liquid Biopsy in Type 2 Diabetes Mellitus Management: Building Specific Biosignatures via Machine Learning. Journal of Clinical Medicine. 2022; 11(4):1045.
https://doi.org/10.3390/jcm11041045
Chicago/Turabian Style
Karaglani, Makrina, Maria Panagopoulou, Christina Cheimonidi, Ioannis Tsamardinos, Efstratios Maltezos, Nikolaos Papanas, Dimitrios Papazoglou, George Mastorakos, and Ekaterini Chatzaki.
2022. "Liquid Biopsy in Type 2 Diabetes Mellitus Management: Building Specific Biosignatures via Machine Learning" Journal of Clinical Medicine 11, no. 4: 1045.
https://doi.org/10.3390/jcm11041045
APA Style
Karaglani, M., Panagopoulou, M., Cheimonidi, C., Tsamardinos, I., Maltezos, E., Papanas, N., Papazoglou, D., Mastorakos, G., & Chatzaki, E.
(2022). Liquid Biopsy in Type 2 Diabetes Mellitus Management: Building Specific Biosignatures via Machine Learning. Journal of Clinical Medicine, 11(4), 1045.
https://doi.org/10.3390/jcm11041045